MIF and Uterine leiomyoma: In the current study, our results revealed that MIF, as one antagonist of progesterone receptor, is capable of inhibiting the autophagy and apoptosis of PR-M(+) uterine leiomyoma cells by regulating Bcl/Beclin1 axis.